COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL

Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized...

詳細記述

保存先:
書誌詳細
主要な著者: S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
フォーマット: Artigo
言語:Inglês
出版事項: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
シリーズ:Racionalʹnaâ Farmakoterapiâ v Kardiologii
主題:
arterial hypertension
overweight
obesity
beta-blockers
carvedilol
metoprolol
オンライン･アクセス:https://www.rpcardio.com/jour/article/view/617
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料